Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 (everolimus) in breast cancer patients with bone metastases
2005-005835-87Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of everolimus in breast cancer and bone metastases (3 arms), sponsored by GBG Forschungs. Primary endpoint: time to progression. Started Jun 2006; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancerbone metastases
Beyond the preview
Go deeper on 2005-005835-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005835-87.